The coexpression of GLUT1 and MCT4 promotes cancer progression in various cancers, such as ovarian cancer (Baczewska et al., 2022) and hepatocellular carcinoma (Granja et al., 2022). Here, SLC16A3 is linked to hepatocellular carcinoma.